BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 8736340)

  • 1. An acquired bullous dermatosis due to an autoimmune reaction against uncein.
    Horiguchi Y; Ueda M; Shimizu H; Tanaka T; Matsuyoshi N; Utani A; Ikai K; Nishikawa T; Imamura S
    Br J Dermatol; 1996 May; 134(5):934-8. PubMed ID: 8736340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coexistence of psoriasis and an unusual IgG-mediated subepidermal bullous dermatosis: identification of a novel 200-kDa lower lamina lucida target antigen.
    Chen KR; Shimizu S; Miyakawa S; Ishiko A; Shimizu H; Hashimoto T
    Br J Dermatol; 1996 Feb; 134(2):340-6. PubMed ID: 8746353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel immune-mediated subepidermal bullous dermatosis characterized by IgG autoantibodies to a lower lamina lucida component.
    Chan LS; Cooper KD
    Arch Dermatol; 1994 Mar; 130(3):343-7. PubMed ID: 8129413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A subepidermal blistering dermatosis associated with coexistent IgG and IgA anti-dermal basement membrane zone antibodies; demonstration of IgG antibodies reactive against a 200-kDa dermal antigen.
    Watanabe M; Tsunoda T; Tagami H
    Eur J Dermatol; 2002; 12(6):603-6. PubMed ID: 12459541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transient intraepidermal bullous reaction after skin graft for toxic epidermal necrolysis. Ultrastructural and immunohistochemical features similar to those of inherited epidermolysis bullosa simplex.
    Bourgault I; Prost C; André C; Villada G; Wechsler J; Chosidow O; Revuz J
    Arch Dermatol; 1991 Sep; 127(9):1369-74. PubMed ID: 1892406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A case of mixed bullous disease of epidermolysis bullosa acquisita and linear IgA bullous dermatosis.
    Osawa M; Demitsu T; Toda S; Yokokura H; Umemoto N; Yamada T; Yoneda K; Kakurai M; Yoshida M; Hashimoto T
    Dermatology; 2005; 211(2):146-8. PubMed ID: 16088162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel subepidermal blistering disease with autoantibodies to a 200-kDa antigen of the basement membrane zone.
    Zillikens D; Kawahara Y; Ishiko A; Shimizu H; Mayer J; Rank CV; Liu Z; Giudice GJ; Tran HH; Marinkovich MP; Bröcker EB; Hashimoto T
    J Invest Dermatol; 1996 Mar; 106(3):465-70. PubMed ID: 8648178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Linear IgA bullous dermatosis. Characterization of a subset of patients with concurrent IgA and IgG anti-basement membrane autoantibodies.
    Chan LS; Traczyk T; Taylor TB; Eramo LR; Woodley DT; Zone JJ
    Arch Dermatol; 1995 Dec; 131(12):1432-7. PubMed ID: 7492134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alterations of basement membrane zone in autoimmune subepidermal bullous diseases.
    Woźniak K; Kowalewski C
    J Dermatol Sci; 2005 Dec; 40(3):169-75. PubMed ID: 15990279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and partial characterization of a novel 105-kDalton lower lamina lucida autoantigen associated with a novel immune-mediated subepidermal blistering disease.
    Chan LS; Fine JD; Briggaman RA; Woodley DT; Hammerberg C; Drugge RJ; Cooper KD
    J Invest Dermatol; 1993 Sep; 101(3):262-7. PubMed ID: 8370962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Linear immunoglobulin A (IgA) bullous dermatosis of childhood: identification of the target antigens and study of the cellular sources.
    Yamane Y; Sato H; Higashi K; Yaoita H
    Br J Dermatol; 1996 Nov; 135(5):785-90. PubMed ID: 8977683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Orf-induced immunobullous disease: A distinct autoimmune blistering disorder.
    White KP; Zedek DC; White WL; Simpson EL; Hester E; Morrison L; Lazarova Z; Liu D; Scagliarini A; Kurtz SE; White CR; Yancey KB; Blauvelt A
    J Am Acad Dermatol; 2008 Jan; 58(1):49-55. PubMed ID: 17919774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical, ultrastructural, and molecular features of Kindler syndrome distinguish it from dystrophic epidermolysis bullosa.
    Shimizu H; Sato M; Ban M; Kitajima Y; Ishizaki S; Harada T; Bruckner-Tuderman L; Fine JD; Burgeson R; Kon A; McGrath JA; Christiano AM; Uitto J; Nishikawa T
    Arch Dermatol; 1997 Sep; 133(9):1111-7. PubMed ID: 9301588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A case of linear IgA bullous dermatosis with IgA anti-type VII collagen autoantibodies.
    Hashimoto T; Ishiko A; Shimizu H; Tanaka T; Dodd HJ; Bhogal BS; Black MM; Nishikawa T
    Br J Dermatol; 1996 Feb; 134(2):336-9. PubMed ID: 8746352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psoriasis vulgaris coexistent with epidermolysis bullosa acquisita.
    Endo Y; Tamura A; Ishikawa O; Miyachi Y; Hashimoto T
    Br J Dermatol; 1997 Nov; 137(5):783-6. PubMed ID: 9415242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A case of autoimmune bullous dermatosis with features of pemphigus vulgaris and bullous pemphigoid.
    Kore-eda S; Horiguchi Y; Ohtoshi E; Tanaka T; Fujii K; Okamoto H; Ikai K; Imamura S
    Am J Dermatopathol; 1995 Oct; 17(5):511-6. PubMed ID: 8599459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intercellular IgA dermatosis with clinical features of subcorneal pustular dermatosis.
    Hashimoto T; Inamoto N; Nakamura K; Nishikawa T
    Arch Dermatol; 1987 Aug; 123(8):1062-5. PubMed ID: 3307637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antigenic and morphologic regeneration of epidermal basement membrane in short term organ culture of human skin.
    Brickman F; Soltani K; Medenica M; Taylor ME
    Lab Invest; 1977 Mar; 36(3):296-302. PubMed ID: 320385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monoclonal antibody GB3 defines a widespread defect of several basement membranes and a keratinocyte dysfunction in patients with lethal junctional epidermolysis bullosa.
    Verrando P; Blanchet-Bardon C; Pisani A; Thomas L; Cambazard F; Eady RA; Schofield O; Ortonne JP
    Lab Invest; 1991 Jan; 64(1):85-92. PubMed ID: 1990210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel antigen of the dermal-epidermal junction defined by an anti-CD1b monoclonal antibody (NU-T2).
    Kanitakis J; Zambruno G; Wang YZ; Roche P; Berti E; Schmitt D
    Arch Dermatol Res; 1993; 285(6):313-21. PubMed ID: 8215581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.